Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma
破译异常内源性逆转录病毒表达在肿瘤组蛋白驱动的神经胶质瘤中的作用
基本信息
- 批准号:10658655
- 负责人:
- 金额:$ 57.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylationAntiviral ResponseBindingBiologyBrainBrain NeoplasmsCell MaintenanceCell ProliferationCell modelCellsComplexDNADNA MethylationDepositionDetectionDevelopmentDouble-Stranded RNAElectroporationElementsEnzyme ActivationEvolutionFamily memberFunctional disorderGenetic TranscriptionGliomaH3 K27M mutationHistone AcetylationHistone H3HistonesHumanHuman GenomeImpairmentInterferon Type IKnock-outLysineMaintenanceMalignant NeoplasmsMalignant neoplasm of brainMethionineMethylationMitochondriaModelingMutateMutationPathway interactionsPatientsPatternPlayPolycombReaderRecurrenceRegulationRegulatory PathwayRepetitive SequenceRoleSignal PathwaySignal TransductionTestingTherapeuticTranscriptional ActivationTranslational RepressionViralVirus Diseasesanti-cancerbaseblastomere structurecancer cellembryonic stem cellepigenetic silencingexperimental studygene repressiongenetic approachhelicasehistone modificationin uteroinhibitorinsightneoplastic cellnerve stem cellneural growthnovelnovel therapeutic interventiononcohistoneoverexpressionresponseself-renewalstem cell differentiationtranscription factortumortumorigenesis
项目摘要
ABSTRACT
The polycomb repressive complex 2 (PRC2) is recurrently disrupted in brain cancer; a complex required for
depositing the repressive histone modification, H3K27 tri-methylation (H3K27me3). Maintenance of PRC2
function is important for repression of genes and repetitive elements, providing a safe-guard against aberrant
transcription. PRC2 is essential for proper embryonic cell maintenance, neural stem cell differentiation, and
overall brain development. How PRC2 dysfunction and aberrant H3K27me3 levels contributes to brain
tumorigenesis is unclear. As a model of PRC2 dysfunction in brain tumors, our lab investigates midline high
grade gliomas (HGG) that harbor frequent histone H3 lysine 27 to methionine mutations (denoted H3K27M).
Expression of H3K27M impairs PRC2 function and results in a global loss of H3K27me3; a defining feature of
these brain tumors. Using isogenic glioma models in which H3K27M is deleted, we found that the H3K27M
results in a global increase in a mark of active transcription, H3K27 acetylation (H3K27ac) (Krug et al., Cancer
Cell, 2019). Surprisingly, global H3K27ac has minimal effects on gene transcription. Instead, we discovered a
novel mechanism of H3K27ac associated transcription of repetitive DNA elements, namely Type-H human
endogenous retroviral (HERV) sequences. We hypothesize that: 1) HERV activation plays a functional role in
the biology of H3K27M-driven glioma, and 2) Amplification of HERV expression represents a novel anti-cancer
strategy against tumors with global loss of H3K27me3. To test this hypothesis we propose three specific aims
to: 1) Decipher the mechanisms of HERV transcriptional activation in H3K27M-driven glioma, 2) Determine the
impact of HERV expression on H3K27M-glioma cell identity and tumor formation, and 3) Delineate the
mechanisms of HERV detection and response in H3K27M-glioma. Collectively these experiments will reveal
mechanistic insight into the role of HERV expression in high-grade glioma and cellular vulnerabilities created by
H3K27M mutations.
抽象的
多梳抑制复合物 2 (PRC2) 在脑癌中反复遭到破坏;需要一个复杂的
沉积抑制性组蛋白修饰,H3K27 三甲基化 (H3K27me3)。 PRC2的维护
功能对于基因和重复元件的抑制很重要,可以防止异常
转录。 PRC2 对于胚胎细胞的正常维持、神经干细胞分化和
大脑整体发育。 PRC2 功能障碍和异常 H3K27me3 水平如何影响大脑
肿瘤发生机制尚不清楚。作为脑肿瘤中 PRC2 功能障碍的模型,我们的实验室研究了中线高
具有频繁的组蛋白 H3 赖氨酸 27 到蛋氨酸突变(表示为 H3K27M)的级别神经胶质瘤 (HGG)。
H3K27M 的表达会损害 PRC2 功能并导致 H3K27me3 整体缺失;的一个决定性特征
这些脑肿瘤。使用删除了 H3K27M 的同基因神经胶质瘤模型,我们发现 H3K27M
导致活性转录标记 H3K27 乙酰化 (H3K27ac) 整体增加(Krug 等人,癌症
细胞,2019)。令人惊讶的是,全局 H3K27ac 对基因转录的影响极小。相反,我们发现了一个
H3K27ac 相关重复 DNA 元件(即 H 型人类)转录的新机制
内源性逆转录病毒(HERV)序列。我们假设:1)HERV 激活在以下方面发挥功能性作用:
H3K27M 驱动的神经胶质瘤的生物学特性,以及 2) HERV 表达的扩增代表了一种新型抗癌药物
针对 H3K27me3 整体缺失的肿瘤的策略。为了检验这一假设,我们提出了三个具体目标
目的:1) 破译 H3K27M 驱动的神经胶质瘤中 HERV 转录激活的机制,2) 确定
HERV 表达对 H3K27M-神经胶质瘤细胞身份和肿瘤形成的影响,以及 3) 描绘
H3K27M-神经胶质瘤中 HERV 检测和反应的机制。总的来说,这些实验将揭示
深入了解 HERV 表达在高级神经胶质瘤和细胞脆弱性中的作用
H3K27M 突变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen C Mack其他文献
Transposase-driven rearrangements in human tumors
转座酶驱动的人类肿瘤重排
- DOI:
10.1038/ng.3908 - 发表时间:
2017-07-01 - 期刊:
- 影响因子:29.000
- 作者:
Stephen C Mack;Hiromichi Suzuki;Michael D Taylor - 通讯作者:
Michael D Taylor
Stephen C Mack的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen C Mack', 18)}}的其他基金
Role of FACT in ZFTA-RelA fusion driven ependymoma
FACT 在 ZFTA-RelA 融合驱动的室管膜瘤中的作用
- 批准号:
10638244 - 财政年份:2023
- 资助金额:
$ 57.61万 - 项目类别:
Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma
破译异常内源性逆转录病毒表达在肿瘤组蛋白驱动的神经胶质瘤中的作用
- 批准号:
9945835 - 财政年份:2020
- 资助金额:
$ 57.61万 - 项目类别:
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 57.61万 - 项目类别:
Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 57.61万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 57.61万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 57.61万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 57.61万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
- 批准号:
10640247 - 财政年份:2021
- 资助金额:
$ 57.61万 - 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
- 批准号:
10322026 - 财政年份:2021
- 资助金额:
$ 57.61万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
- 批准号:
10438876 - 财政年份:2021
- 资助金额:
$ 57.61万 - 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
- 批准号:
10629440 - 财政年份:2021
- 资助金额:
$ 57.61万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 57.61万 - 项目类别: